Assessment and Management of the Patient with Graves’ Ophthalmopathy
- 1 May 1995
- journal article
- Published by Elsevier in Endocrine Practice
- Vol. 1 (3) , 172-178
- https://doi.org/10.4158/ep.1.3.172
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Expression of thyrotropin-receptor mRNA in healthy and Graves' disease retro-orbital tissueThe Lancet, 1993
- Detection and localization of cytokine immunoreactivity in retro‐ocular connective tissue in Graves' opthalmopathyEuropean Journal of Clinical Investigation, 1993
- Detection of TSH Receptor RNA in Cultured Fibroblasts from Patients with Graves' Ophthalmopathy and Pretibial DermopathyThyroid®, 1993
- Regulation by glucocorticoids of interferon gamma‐induced HLA‐DR antigen expression in cultured human orbital fibroblastsClinical Endocrinology, 1992
- Occurrence of Ophthalmopathy after Treatment for Graves' HyperthyroidismNew England Journal of Medicine, 1992
- Association between Graves' ophthalmopathy and smokingThe Lancet, 1990
- Prednisone and Cyclosporine in the Treatment of Severe Graves' OphthalmopathyNew England Journal of Medicine, 1989
- Use of Corticosteroids to Prevent Progression of Graves' Ophthalmopathy after Radioiodine Therapy for HyperthyroidismNew England Journal of Medicine, 1989
- Immunosuppressant therapy of thyroid eye diseaseJournal of Molecular Medicine, 1988
- Is endocrine ophthalmopathy related to smoking?BMJ, 1987